Foghorn Therapeutics Inc (FHTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 12-2019 | 12-2017 | 12-2006 | |
| Sales | 430 | 0 | 0 | 0 |
| Gross Profit | 430 | N/A | N/A | N/A |
| Operating Expenses | 68,961 | 51,084 | 0 | 0 |
| Operating Income | -68,531 | -51,084 | N/A | N/A |
| Interest Expense | 979 | 540 | 0 | 0 |
| Other Income | 710 | 496 | 0 | 0 |
| Pre-tax Income | -68,800 | -51,128 | 0 | 0 |
| Net Income Continuous | -68,800 | -51,128 | N/A | N/A |
| Net Income | $-68,800 | $-51,128 | $N/A | $N/A |
| EPS Basic Total Ops | -6.23 | -12.20 | N/A | N/A |
| EPS Basic Continuous Ops | -6.23 | -12.20 | N/A | N/A |
| EPS Diluted Total Ops | -6.23 | -12.20 | N/A | N/A |
| EPS Diluted Continuous Ops | -6.23 | -12.20 | N/A | N/A |
| EPS Diluted Before Non-Recurring Items | -6.23 | N/A | N/A | N/A |
| EBITDA(a) | $-67,205 | $-50,391 | $N/A | $N/A |